Additional evidence on the phenotype produced by combination of

1677delTA L997F cystic fibrosis cystic fibrosis transmembrane conductance regulator

Journal

SAGE open medical case reports
ISSN: 2050-313X
Titre abrégé: SAGE Open Med Case Rep
Pays: England
ID NLM: 101638686

Informations de publication

Date de publication:
2023
Historique:
received: 28 11 2022
accepted: 04 05 2023
pubmed: 5 6 2023
medline: 5 6 2023
entrez: 5 6 2023
Statut: epublish

Résumé

Cystic fibrosis is the most common, life-threatening, autosomal recessive disease in the Caucasian population. It is caused by mutations in the cystic fibrosis transmembrane conductance regulator gene, which encodes a chloride ion channel expressed on the surface of epithelial cells. There are more than 2000 variants of the cystic fibrosis transmembrane conductance regulator gene reported worldwide. Some of these variants cause classic cystic fibrosis, while others are labeled as variants of unknown significance or variants of varying clinical consequences alleles and associated with atypical disease or cystic fibrosis transmembrane conductance regulator-related disorders. Although these alleles do not directly cause cystic fibrosis, they may predispose compound heterozygous patients to certain clinical phenotypes. Specifically, 1677delTA has been reported as a pathogenic allele in homozygous state or in combination with other cystic fibrosis-causing alleles. However, the L997F allele is considered to be benign or causative of non-classic cystic fibrosis or cystic fibrosis transmembrane conductance regulator-related disorders in combination with other pathogenic alleles. In this case series, we describe three cases with 1677delTA and L997F genotype, and speculate that a co-concurrence of these two alleles in

Identifiants

pubmed: 37274939
doi: 10.1177/2050313X231177163
pii: 10.1177_2050313X231177163
pmc: PMC10233568
doi:

Types de publication

Case Reports

Langues

eng

Pagination

2050313X231177163

Informations de copyright

© The Author(s) 2023.

Déclaration de conflit d'intérêts

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Tinatin Tkemaladze (T)

Department of Molecular and Medical Genetics, Tbilisi State Medical University, Tbilisi, Georgia.
Department of Pediatrics, Givi Zhvania Pediatric Academic Clinic, Tbilisi State Medical University, Tbilisi, Georgia.

Eka Kvaratskhelia (E)

Department of Molecular and Medical Genetics, Tbilisi State Medical University, Tbilisi, Georgia.
Bakhutashvili Institute of Medical Biotechnology, Tbilisi State Medical University, Tbilisi, Georgia.

Mariam Ghughunishvili (M)

Department of Molecular and Medical Genetics, Tbilisi State Medical University, Tbilisi, Georgia.
Department of Pediatrics, Givi Zhvania Pediatric Academic Clinic, Tbilisi State Medical University, Tbilisi, Georgia.

Irakli Rtskhiladze (I)

Medical Center Mrcheveli, Tbilisi, Georgia.

Zurab Zaalishvili (Z)

Department of Molecular and Medical Genetics, Tbilisi State Medical University, Tbilisi, Georgia.

Nata Nakaidze (N)

Department of Molecular and Medical Genetics, Tbilisi State Medical University, Tbilisi, Georgia.

Michael J Lentze (MJ)

Department of Pediatrics, Children's Hospital Medical Center, University Hospitals Bonn, Bonn, Germany.

Elene Abzianidze (E)

Department of Molecular and Medical Genetics, Tbilisi State Medical University, Tbilisi, Georgia.

Volha Skrahina (V)

Centogene GmbH, Rostock, Germany.
Arcensus GmbH, Rostock, Germany.

Arndt Rolfs (A)

Centogene GmbH, Rostock, Germany.
Arcensus GmbH, Rostock, Germany.
Medical Faculty, University of Rostock, Rostock, Germany.

Classifications MeSH